REN-1654 in Sciatica: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects with Pain due to Lumbosacral Radiculopathy

Trial ID or NCT#

NCT00107055

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to gain initial safety and efficacy data on the experimental agent REN-1654 in patients with pain that radiates down the leg(s), and is typical of sciatica (lumbosacral radiculopathy). These patients will usually have a herniated disc that is causing compression on the nerves coming out of the spinal column.